Skip to main content

Hospital Electronic Prescribing and Medicines Administration (HEPMA) Data - Scotland

Data Provision Notice to provide NHS Digital with prescribing and medicines data from NHS Health Boards in Scotland using WellSky HEPMA systems, to support COVID-19 analysis, planning and research activity.


National Services Scotland (NSS) has requested NHS Digital to collect and analyse Hospital Electronic Prescribing and Medicines Administration (HEPMA) data from four NHS Health Boards in Scotland for COVID-19 purposes. The data will be disseminated back to NSS to support the NHS in Scotland and Scottish Government’s response to the COVID-19 pandemic.

The data collected will include:

  • what medicines have been prescribed to patients in hospital settings
  • how and when the medicine was taken by the patient (administration)
  • the reasons for prescribing if this is available (known as indications)
  • the patient’s CHI number
  • what stage of the patient’s journey through the hospital the data relates to (where available).

Scope of the collection

This Notice is served on:

  • the four NHS Health Boards in Scotland using WellSky HEPMA systems which have agreed to participate in the collection.

Legal basis for provision of data

Period of the collection

Specific collection dates will be agreed with the individual Health Boards.

Initially the collection will take data from 1 January 2020, to be followed by a further historic collection of data from 1 January 2019. Once this is completed, submissions will start on a daily basis.

A formal review will take place with NHSX and Public Health Scotland before 30 September 2020 when the first six monthly review under the COVID-19 National Services Scotland Non-Mandatory Request 2020 is due to take place.

Read the Data Provision Notice

Last edited: 9 September 2020 9:21 am